Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
FTRE is expected to report earnings to rise 127.78% to 40 cents per share on May 19
Q1'25
Est.
$0.41
Q4'24
Missed
by $0.24
Q3'24
Missed
by $0.09
Q2'24
Missed
by $0.27
Q1'24
Missed
by $0.23
The last earnings report on March 03 showed earnings per share of 18 cents, missing the estimate of 41 cents. With 7.02K shares outstanding, the current market capitalization sits at 906.51M.